Dean O Takaoka
Examiner (ID: 1788, Phone: (571)272-1772 , Office: P/2842 )
Most Active Art Unit | 2817 |
Art Unit(s) | 2843, 2842, 2817 |
Total Applications | 1929 |
Issued Applications | 1744 |
Pending Applications | 52 |
Abandoned Applications | 133 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18477083
[patent_doc_number] => 11690807
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Implantable device for sustained release of a macromolecular drug compound
[patent_app_type] => utility
[patent_app_number] => 16/416325
[patent_app_country] => US
[patent_app_date] => 2019-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 10988
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16416325
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/416325 | Implantable device for sustained release of a macromolecular drug compound | May 19, 2019 | Issued |
Array
(
[id] => 16868519
[patent_doc_number] => 20210161986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => CAFFEINE COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/048551
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048551
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048551 | CAFFEINE COMPOSITIONS AND METHODS OF USE | Apr 14, 2019 | Pending |
Array
(
[id] => 17974250
[patent_doc_number] => 11491087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Method of capturing and stabilising thiols
[patent_app_type] => utility
[patent_app_number] => 17/045577
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4423
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/045577 | Method of capturing and stabilising thiols | Apr 11, 2019 | Issued |
Array
(
[id] => 14926493
[patent_doc_number] => 20190298884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => BONE MATRIX COMPOSITIONS AND METHODS FOR THEIR PREPARATION AND USE
[patent_app_type] => utility
[patent_app_number] => 16/378838
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16378838
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/378838 | BONE MATRIX COMPOSITIONS AND METHODS FOR THEIR PREPARATION AND USE | Apr 8, 2019 | Abandoned |
Array
(
[id] => 17405983
[patent_doc_number] => 11246843
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Method for increasing plasma concentration of epinephrine in a subject having a condition responsive to epinephrine
[patent_app_type] => utility
[patent_app_number] => 16/377810
[patent_app_country] => US
[patent_app_date] => 2019-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 11367
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16377810
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/377810 | Method for increasing plasma concentration of epinephrine in a subject having a condition responsive to epinephrine | Apr 7, 2019 | Issued |
Array
(
[id] => 14926013
[patent_doc_number] => 20190298644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => HAIR DENSIFYING AGENT AND DISPENSER
[patent_app_type] => utility
[patent_app_number] => 16/376424
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376424
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/376424 | HAIR DENSIFYING AGENT AND DISPENSER | Apr 4, 2019 | Abandoned |
Array
(
[id] => 14960435
[patent_doc_number] => 20190307695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => HEMP POWDER
[patent_app_type] => utility
[patent_app_number] => 16/376855
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376855
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/376855 | HEMP POWDER | Apr 4, 2019 | Abandoned |
Array
(
[id] => 18186299
[patent_doc_number] => 11576856
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Method for making injectable pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 17/050019
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 8
[patent_no_of_words] => 13809
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050019
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050019 | Method for making injectable pharmaceutical compositions | Apr 1, 2019 | Issued |
Array
(
[id] => 17035139
[patent_doc_number] => 20210252097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => POLYPHARMACEUTICAL DRUG COMPOSITIONS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/044696
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044696
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044696 | Polypharmaceutical drug compositions and related methods | Apr 1, 2019 | Issued |
Array
(
[id] => 14926053
[patent_doc_number] => 20190298664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => METHOD AND KIT FOR MYOCARDIAL REPERFUSION, AND METHOD FOR ATTENUATING OR REDUCING MYOCARDIAL REPERFUSION INJURY
[patent_app_type] => utility
[patent_app_number] => 16/368654
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16368654
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/368654 | METHOD AND KIT FOR MYOCARDIAL REPERFUSION, AND METHOD FOR ATTENUATING OR REDUCING MYOCARDIAL REPERFUSION INJURY | Mar 27, 2019 | Abandoned |
Array
(
[id] => 14926089
[patent_doc_number] => 20190298682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => PACA AND CABAZITAXEL FOR ANTI-CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/366596
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16366596
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/366596 | PACA and cabazitaxel for anti-cancer treatment | Mar 26, 2019 | Issued |
Array
(
[id] => 15405173
[patent_doc_number] => 20200022908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => METHOD FOR TREATING MYOPIA AND APPLICATION IN PREPARATION OF MEDICAMENT
[patent_app_type] => utility
[patent_app_number] => 16/486785
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486785
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486785 | METHOD FOR TREATING MYOPIA AND APPLICATION IN PREPARATION OF MEDICAMENT | Mar 21, 2019 | Abandoned |
Array
(
[id] => 14563747
[patent_doc_number] => 20190209480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => PHARMACEUTICAL COMPOSITIONS CONFIGURED TO DETER DOSAGE FORM SPLITTING
[patent_app_type] => utility
[patent_app_number] => 16/360865
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360865
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/360865 | PHARMACEUTICAL COMPOSITIONS CONFIGURED TO DETER DOSAGE FORM SPLITTING | Mar 20, 2019 | Abandoned |
Array
(
[id] => 16539176
[patent_doc_number] => 20200405589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => SOLID-FORM COSMETIC
[patent_app_type] => utility
[patent_app_number] => 16/980929
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980929
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980929 | SOLID-FORM COSMETIC | Mar 14, 2019 | Abandoned |
Array
(
[id] => 14531487
[patent_doc_number] => 20190201364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND NICOTINIC ACID AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/351376
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16351376
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/351376 | PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND NICOTINIC ACID AND METHODS OF USING SAME | Mar 11, 2019 | Abandoned |
Array
(
[id] => 14621527
[patent_doc_number] => 20190224131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => DELAYED-RELEASE FORMULATIONS, METHODS OF MAKING AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/294165
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16294165
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/294165 | DELAYED-RELEASE FORMULATIONS, METHODS OF MAKING AND USE THEREOF | Mar 5, 2019 | Abandoned |
Array
(
[id] => 14743855
[patent_doc_number] => 20190255101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => DIFFERENTIAL TUMOR CELL CYTOTOXICITY VIA CONTACT WITH COATED CERIUM OXIDE NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/284784
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16284784
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/284784 | DIFFERENTIAL TUMOR CELL CYTOTOXICITY VIA CONTACT WITH COATED CERIUM OXIDE NANOPARTICLES | Feb 24, 2019 | Abandoned |
Array
(
[id] => 18368039
[patent_doc_number] => 11648185
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Method for producing powder leads and products produced therewith
[patent_app_type] => utility
[patent_app_number] => 16/970468
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4966
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970468 | Method for producing powder leads and products produced therewith | Feb 14, 2019 | Issued |
Array
(
[id] => 14849567
[patent_doc_number] => 10413487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => Nail gel polish and its manufacturing method
[patent_app_type] => utility
[patent_app_number] => 16/268356
[patent_app_country] => US
[patent_app_date] => 2019-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3643
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16268356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/268356 | Nail gel polish and its manufacturing method | Feb 4, 2019 | Issued |
Array
(
[id] => 14306489
[patent_doc_number] => 20190142948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => AQUEOUS BASED CAPSAICINOID FORMULATIONS AND METHODS OF MANUFACTURE AND USE
[patent_app_type] => utility
[patent_app_number] => 16/244896
[patent_app_country] => US
[patent_app_date] => 2019-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16244896
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/244896 | AQUEOUS BASED CAPSAICINOID FORMULATIONS AND METHODS OF MANUFACTURE AND USE | Jan 9, 2019 | Abandoned |